Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04125368 · ClinicalTrials.gov registry record · NA
A Feasibility Study of Integrating Maternal Nutrition Interventions Into Antenatal Care Services in Ethiopia
A NA study of Maternal Dietary Diversity and Iron-Folic Acid Supplementation, sponsored by International Food Policy Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 4,256
- Enrollment target
- 1
- Study location
NCT04125368: Completed NA study of Maternal Dietary Diversity and Iron-Folic Acid Supplementation, sponsored by International Food Policy Research Institute.
NCT04125368 is a NA study of Maternal Dietary Diversity and Iron-Folic Acid Supplementation that has completed, run by International Food Policy Research Institute. The registered enrollment target is 4,256 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (203% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04125368, a NA study of Maternal Dietary Diversity and Iron-Folic Acid Supplementation, has completed, sponsored by International Food Policy Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,256 participants
- Enrollment target
- 1
- Study location
Study Summary
Alive \& Thrive (A\&T) is an initiative that supports the scaling up of nutrition interventions to save lives, prevent illnesses, and contribute to healthy growth and development through improved maternal nutrition, breastfeeding and complementary feeding practices. In Ethiopia, A\&T integrated a package of maternal nutrition interventions into existing antenatal care (ANC) services delivered through government health facilities (counselling on diet quality during pregnancy, distribution and promotion of iron-folic acid (IFA) supplementation, weight gain monitoring, counselling on early breastfeeding practices, and systems strengthening through training and supportive supervision) and community platforms (home visits, Pregnant Women Conferences/Mother Support groups, and community gatherings). The evaluation used a two-arm cluster-randomized, non-masked trial design, consisting of two cross-sectional surveys in 2019 and 2021.
Primary Outcome
Mean number of food groups consumed by pregnant women on the day preceding the interview.
Conditions Studied
Interventions
- BEHAVIORAL Health Facility Interventions
- BEHAVIORAL Community Interventions
- BEHAVIORAL Health System Interventions
Study Locations (1)
District of Columbia
- International Food Policy Research Institute - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,256 participants |
| Start Date | 2019-10-08 |
| Est. Completion | 2021-09-04 |
| Phase | NA |
What the finished NCT04125368 record still lists
NCT04125368 is an interventional study that assigns participants to a tested intervention. Its 4,256 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (203% higher).
The record links to 3 conditions, with Maternal Dietary Diversity appearing as the primary indexed condition, and to 3 interventions - of which Health Facility Interventions is the first listed.
NCT04125368 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04125368 about?
NCT04125368 is a clinical study titled "A Feasibility Study of Integrating Maternal Nutrition Interventions Into Antenatal Care Services in Ethiopia". Alive \& Thrive (A\&T) is an initiative that supports the scaling up of nutrition interventions to save lives, prevent illnesses, and contribute to healthy growth and development through improved maternal nutrition, breastfeeding and complementary feeding practices. In Ethiopia, A\&T integrated a pa...
What is the current status of trial NCT04125368?
This trial is currently completed. It is a NA study. The enrollment target is 4,256 participants. The study started on 2019-10-08. Estimated completion is 2021-09-04.
What conditions does trial NCT04125368 study?
This clinical trial studies the following conditions: Maternal Dietary Diversity, Iron-Folic Acid Supplementation, Early Initiation of Breastfeeding.
What interventions are being tested in trial NCT04125368?
The interventions under investigation include: Health Facility Interventions (BEHAVIORAL), Community Interventions (BEHAVIORAL), Health System Interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04125368?
This trial is sponsored by International Food Policy Research Institute, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04125368 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04125368's enrollment target sits among peer trials
4,256 30th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05543616 · 4,292 participants · Phase 2
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
- NCT06492616 · 4,220 participants · Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- NCT05774951 · 4,300 participants · Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI